ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
4.7827
0.00
( 0.00% )
Actualizado: 08:19:14
Realtime Data

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
4.7827
Postura de Compra
4.7729
Postura de Venta
4.7774
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
4.7827
Precio de Apertura
-
Hora
Última hora de negociación
-
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

CBUS Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
BNOXBionomics Ltd
US$ 0.4679
(144.67%)
111.17M
AGFYAgrify Corporation
US$ 6.22
(98.09%)
8.75M
ALBTAvalon GloboCare Corporation
US$ 4.20
(87.50%)
21.92M
ZVSAZyVersa Therapeutics Inc
US$ 2.61
(43.41%)
15.41M
SPPLSIMPPLE Ltd
US$ 1.67
(41.53%)
24.37M
MQMarqeta Inc
US$ 3.97
(-33.28%)
3.43M
VRCAVerrica Parmaceuticals Inc
US$ 0.96
(-32.87%)
95.29k
EPRXEupraxia Pharmaceuticals Inc
US$ 2.65
(-23.74%)
37
FAASDigiAsia Corporation
US$ 0.75
(-16.67%)
19.04k
DCBODocebo Inc
US$ 40.50
(-15.70%)
10
ELABElevai Labs Inc
US$ 0.02495
(24.13%)
178.98M
BNOXBionomics Ltd
US$ 0.4679
(144.67%)
111.17M
SPPLSIMPPLE Ltd
US$ 1.67
(41.53%)
24.37M
ALBTAvalon GloboCare Corporation
US$ 4.20
(87.50%)
21.92M
ZVSAZyVersa Therapeutics Inc
US$ 2.61
(43.41%)
15.41M
Bigtrade PT Bigtrade PT 1 minuto hace
I don't believe in this climb... it's going to fall more...
ELAB
$treet Trader $treet Trader 2 minutos hace
Good morning A$ & LD
Screech691 Screech691 2 minutos hace
love SGTM's commitment to sustainability with their living mulch product
COMMITTED TO SUSTAINABILITY
Microbe Living Mulch delivers impressive outcomes for your landscape, including enhanced aesthetic appeal and increased yields for healthier gardens. It aids in carbon sequestration, im
SGTM
02opida 02opida 2 minutos hace
VOTE America
$treet Trader $treet Trader 2 minutos hace
Good morning .0001ers
JettaR JettaR 2 minutos hace
Poor abandoned child. 
CBDW
getmoreshares getmoreshares 2 minutos hace
https://x.com/woofknight/status/1853787152342999283
Midwestrader Midwestrader 2 minutos hace
Evidently that CLOWN CAR CEO never really did DD and research on what happens with the pps after a REVERSE SPLIT. He probably thought it would drop a few cents and he'd be DUMPING away at say....0.35. 🤣 🤪

Nah...this POS CON JOB SHAM is now down 78.94% as of close yest
INND
docj docj 3 minutos hace
New SAB member:
Clinton Yam, MD, MS
Dr. Clinton Yam is an Associate Professor with dual appointments in the Departments of Breast Medical Oncology and Translational Molecular Pathology at The University of Texas MD Anderson Cancer Center. Dr. Yam is leader of the triple-negative breast
CYDY
02opida 02opida 3 minutos hace
Good Morning America
BigBadWolf BigBadWolf 3 minutos hace
$ASIInvestors Learned long ago [yt]Wxk1cyYJe-o[/yt]
My $ I base it's use on my DD & highly recommend both the aforementioned to all
ASIINVESTO
getmoreshares getmoreshares 3 minutos hace
https://x.com/woofknight/status/1853787152342999283
StayHumble StayHumble 3 minutos hace
🚩🚩 Hearing there’s a Massive Reverse Split 🚩🚩Coming
https://i.imgflip.com/7idht1.jpg
DJT
jjjjjjjj jjjjjjjj 3 minutos hace
Good buys of 28M shares but only last minute buys will work! All short sellers have no more shares to borrow. They fake the shares by claiming settlement days. Keep doing
1. SET SELL HIGH our shares,
2. SET BUY HIGH at last minute with price limit.
Our time will come unst
MJNA
Eli's Gone Eli's Gone 3 minutos hace
sure LOL---and the Chevys weren't blocking for Byron and Bubba "thinks" something broke just before he allowed fellow Toyota driver Bell to pass him for the crucial 1 point needed....

a few peeps might pay after NASCAR goes over the radio traffic among those teams involved
SHEEPWOLF SHEEPWOLF 3 minutos hace
$ILLR AMONG PREMARKET GAINERS
#TRILLER IS READY TO TAKE OFF↗️
https://investorshub.advfn.com/uimage/uploads/2024/11/5/thfegGAINERS.png
ILLR
Mr.Wolf Mr.Wolf 3 minutos hace
oh contrar. Go to the Q3 management report and look at QoQ sales. Q2 growth was 400%, if you account for 1/3 of Q3 sales being offline the sales would have been approx: $358,000 ($236k/.66). which is 43% sales growth. People like and were buying the product. The challenge is how much customer loyalt
PSYCF
SHEEPWOLF SHEEPWOLF 3 minutos hace
$ILLR AMONG PREMARKET GAINERS
#TRILLER IS READY TO TAKE OFF↗️
https://investorshub.advfn.com/uimage/uploads/2024/11/5/thfegGAINERS.png
ILLR
docj docj 4 minutos hace
Who says they don't? We'll find out in due time. The trial does't start until early next year.
CYDY
TJG TJG 4 minutos hace
It seems there was an update on the Share Structure on Oct 23 Lets see if there are any differences and what they may be

OS is up 200 million and the unrestricted is up 20 million Held at DTC is the same

Oct 23

AFFU Security Details
Share Structur
AFFU DTC
TKS PARTY TKS PARTY 4 minutos hace
Any news at this point will be highly appreciated !!!!!!
CBRF
georgie18 georgie18 4 minutos hace
ALLO...$2.98...News...ALLO-316, an “Off-the-Shelf” AlloCAR T™ Anti-CD70 CAR T Product, is Currently Under Investigation in the Phase 1 TRAVERSE Trial for Patients with Renal Cell Carcinoma (RCC) Previously Treated with Immune Checkpoint Inhibitors and VEGF-Targeting Therapies
Data Presented A
ALLO
GMH* GMH* 4 minutos hace
Link to abstract:
https://jitc.bmj.com/content/12/Suppl_3/A1718
Key take-away:

At a median follow-up of 25.6 months, the ORR (95% CI) in the EGFR-wt subgroup of interest for further studies was 64.3% (35.1%–87.2%). Median DOR in this subgroup was not reached (NR; 95% CI,
IOVA